WARNING: “Buffett Indicator” flashing for first time in 50 years

Warren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indicates the Oracle of Omaha is quietly preparing for a historic market crash. His most reliable crash indicator - the "Buffett indicator" - just flashed red for the first time in 25 years.

Take these 4 steps today to protect your retirement NOW

Andreas Wicki Biography and Net Worth

Director of Pacira BioSciences

Dr. Wicki has served as a director since our inception in December 2006. Dr. Wicki is a life sciences entrepreneur and investor with over 20 years of experience in the pharmaceutical and biotechnology industries. Dr. Wicki has been Chief Executive Officer of HBM Healthcare Investments (Cayman) Ltd. (formerly HBM BioVentures AG) since 2001. From 1998 to 2001, Dr. Wicki was the Senior Vice President of European Analytical Operations at MDS Inc. From 1990 to 1998, he was co-owner and Chief Executive Officer of ANAWA Laboratorien AG and Clinserve AG, two life sciences contract research companies. From 2007 to 2011, he served as a member of the board of directors of PharmaSwiss SA. Previously, Dr. Wicki held board positions on several privately-held companies and companies listed on international exchanges. Dr. Wicki holds an M.Sc. and Ph.D. in chemistry and biochemistry from the University of Bern, Switzerland. He currently serves on the board of directors of Viela Bio, Inc. (Nasdaq: VIE), Buchler GmbH, Harmony Biosciences, Inc. (Nasdaq: HRMY), HBM Healthcare Investments (Cayman) Ltd., and HBM BioCapital Ltd.

What is Andreas Wicki's net worth?: The estimated net worth of Andreas Wicki is at least $40.77 million as of December 14th, 2022. Mr. Wicki owns 2,147,943 shares of Pacira BioSciences stock worth more than $40,767,958 as of December 22nd. This net worth estimate does not reflect any other assets that Mr. Wicki may own. Learn More about Andreas Wicki's net worth.
How do I contact Andreas Wicki?: The corporate mailing address for Mr. Wicki and other Pacira BioSciences executives is 5 SYLVAN WAY SUITE 300, PARSIPPANY NJ, 07054. Pacira BioSciences can also be reached via phone at (813) 553-6680 and via email at [email protected]. Learn More on Andreas Wicki's contact information.
Has Andreas Wicki been buying or selling shares of Pacira BioSciences?: Andreas Wicki has not been actively trading shares of Pacira BioSciences over the course of the past ninety days. Most recently, Andreas Wicki sold 10,601 shares of the business's stock in a transaction on Monday, March 15th. The shares were sold at an average price of $73.68, for a transaction totalling $781,081.68. Following the completion of the sale, the director now directly owns 5,242 shares of the company's stock, valued at $386,230.56. Learn More on Andreas Wicki's trading history.
Who are Pacira BioSciences' active insiders?: Pacira BioSciences' insider roster includes Donald Manning (Insider), Max Reinhardt (Insider), Charles Reinhart, III (CFO), Lauren Riker (VP), David Stack (CEO), Andreas Wicki (Director), Kristen Williams (Insider), and Roy Winston (Insider). Learn More on Pacira BioSciences' active insiders.
Are insiders buying or selling shares of Pacira BioSciences?: In the last twelve months, Pacira BioSciences insiders bought shares 3 times. They purchased a total of 11,176 shares worth more than $136,240.40. In the last twelve months, insiders at the sold shares 11 times. They sold a total of 114,161 shares worth more than $3,423,055.87. The most recent insider tranaction occured on December, 13th when COO Daryl Gaugler sold 500 shares worth more than $9,880.00. Insiders at Pacira BioSciences own 6.4% of the company. Learn More about insider trades at Pacira BioSciences.
Information on this page was last updated on 12/13/2024.

Andreas Wicki Insider Trading History at Pacira BioSciences

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
3/15/2021	Sell	10,601	$73.68	$781,081.68	5,242
3/11/2021	Sell	60,574	$72.70	$4,403,729.80
3/9/2021	Sell	35,137	$70.90	$2,491,213.30
9/9/2020	Sell	2,216	$62.02	$137,436.32
8/13/2020	Sell	34,904	$61.47	$2,145,548.88
8/11/2020	Sell	106,772	$61.32	$6,547,259.04
12/13/2018	Sell	14,527	$46.84	$680,444.68
11/16/2018	Sell	70,498	$47.34	$3,337,375.32
11/12/2018	Sell	5,478	$49.83	$272,968.74
11/9/2018	Sell	58,245	$51.11	$2,976,901.95
8/29/2014	Sell	21,494	$108.11	$2,323,716.34
8/27/2014	Sell	55,813	$108.08	$6,032,269.04
8/26/2014	Sell	24,207	$108.11	$2,617,018.77
8/25/2014	Sell	30,000	$108.07	$3,242,100.00
8/11/2014	Sell	150,000	$101.25	$15,187,500.00
6/6/2014	Sell	67,900	$82.62	$5,609,898.00
6/3/2014	Sell	68,000	$80.69	$5,486,920.00
5/27/2014	Sell	64,400	$77.93	$5,018,692.00
5/21/2014	Sell	3,600	$77.80	$280,080.00
5/8/2014	Sell	23,220	$75.76	$1,759,147.20
5/7/2014	Sell	44,780	$75.78	$3,393,428.40
3/6/2014	Sell	24,887	$80.16	$1,994,941.92
9/11/2013	Sell	17,783	$37.25	$662,416.75
7/22/2013	Sell	75,958	$35.06	$2,663,087.48
7/18/2013	Sell	25,560	$33.45	$854,982.00
7/16/2013	Sell	48,482	$33.28	$1,613,480.96
7/11/2013	Sell	80,000	$31.48	$2,518,400.00
7/5/2013	Sell	44,021	$30.80	$1,355,846.80
7/3/2013	Sell	114,448	$30.21	$3,457,474.08
6/19/2013	Sell	35,407	$29.90	$1,058,669.30
6/17/2013	Sell	50,145	$29.86	$1,497,329.70
6/12/2013	Sell	4,409	$30.00	$132,270.00
6/11/2013	Sell	11,500	$30.00	$345,000.00
6/5/2013	Sell	15,500	$30.26	$469,030.00
6/3/2013	Sell	1,900	$30.00	$57,000.00
5/22/2013	Sell	18,471	$30.00	$554,130.00
5/20/2013	Sell	14,374	$30.00	$431,220.00
3/25/2013	Sell	290,900	$27.95	$8,130,655.00

Andreas Wicki Buying and Selling Activity at Pacira BioSciences

Pacira BioSciences Company Overview

Pacira Biosciences, Inc. is a holding company, which engages in the provision of non-opioid pain management and regenerative health solutions to improve patients’ journeys along the neural pain pathway. Its products include EXPAREL, iovera, and DepoFoam. The company was founded in December 2006 and is headquartered in Tampa, FL.

Today's Range

Now: $18.98

$18.73

$19.80

50 Day Range

MA: $17.64

$16.32

$20.33

2 Week Range

Now: $18.98

$11.16

$35.95

Volume

3,169,894 shs

Average Volume

859,127 shs

Market Capitalization

$876.36 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.8

Did You See Trump’s Bombshell Exec. Order 001?

From Banyan Hill Publishing | Ad

Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minutes of stepping into the Oval Office...

I put all the details together for you here — but please hurry.